Efficacy and safety of efpeglenatide in key patient subgroups from the BALANCE randomized trial, stratified by pre-diabetes status, BMI, and age at baseline Article

Open Access Industry Collaboration International Collaboration

cited authors

  • Pratley, Richard E.; Jacob, Stephan; Baek, Seungjae; Trautmann, Michael E.; Hompesch, Marcus; Han, OakPil; Stewart, John; Sorli, Christopher H.; Shaunik, Alka; Yoon, Kun-Ho

Publication Date

  • January 1, 2022

webpage

published in

category

keywords

  • body mass index
  • glucagon-like peptide 1
  • glycated hemoglobin A
  • weight loss

volume

  • 10

issue

  • 1